Senco Gold vs Titan: Same Industry, One-Sixth the Multiple
THE SNAPSHOT CMP ₹326 Market Cap ₹5,129 Cr P/E (TTM) ~10.6x P/B 2.41x Revenue (TTM) ₹7,773 Cr PAT (TTM) ₹485 Cr 52W H/L ₹406 / ₹276 Promoter Holding 64.5% Stores (Mar-26) 201 FY26 Rev growth +35% Senco is the largest organised jewellery retailer in Eastern India. Founded in 1938, listed in 2023, it runs […]
Innova Captab: Stock Analysis
THE SNAPSHOT-Innova Captab CMP ₹752 Market Cap ₹4,304 Cr P/E (TTM) 32x Book Value ₹178 ROE / ROCE 14.3% / 14.6% 52W H/L ₹1,021 / ₹608 5Y Sales CAGR 27% 5Y PAT CAGR 36% Stock has corrected ~26% from 52W high while earnings power is still building – that gap is what this thesis explores. […]
KMC Speciality Hospitals- Stock Analysis
Most investors looking at Indian hospital stocks instinctively reach for Apollo, Max, Fortis, or Narayana. KMC Speciality Hospitals doesn’t make that list. It’s a sub-₹1,500 Cr market-cap small-cap that operates exactly one hospital – a 450-bed multi-specialty facility in Tiruchirapalli (Trichy), Tamil Nadu – and yet has compounded into one of the more interesting under-the-radar […]
Ceinsys Tech: Picks and Shovels for Digital India
Some businesses look boring on the surface and stay boring. Others look boring and quietly turn into compounding machines because they sit at the intersection of multiple structural tailwinds. Ceinsys Tech — now rebranded CS Tech AI — belongs in the second bucket, but the price action over the past year tells you the market […]
Interarch: The Steel Spine of India’s Next Decade of Capex
Interarch is a mid-cycle, asset-light, net-cash, capital-efficient proxy for the structural shift of Indian construction from concrete to engineered steel — specifically in the pockets where that shift is most economic (data centres, fabs, gigafactories, large warehouses). It’s the #2 player in an industry where the top seven are taking share from an unorganised tail […]
Windlas Biotech: CDMO Compounder Hiding in Plain Sight
Everyone wants to own the next Cipla or Sun Pharma. Nobody wants to own the company that actually makes the pills those brands sell. That’s exactly why Windlas Biotech is interesting. At ₹867 (April 17, 2026), the stock sits ~24% below its 52-week high of ₹1,140, trading at ~27x trailing earnings, a ~3.4x price-to-book, and […]
Tips Music- Catalog is the new Oil
For decades, India’s music catalogues were like untapped oil fields. Labels like Tips spent years acquiring rights — painstakingly, track by track — only to watch their potential choked by piracy, weak copyright enforcement, and telecom bundling that crushed pricing power. Owning a catalogue often meant sitting on an asset earning a trickle of royalties, […]
Clean Science: Pioneering Green Chemistry in a Global Shift
Green Chemistry Pioneer in a Global Shift The Indian specialty chemicals sector has long talked about China+1, import substitution, and green chemistry—but few have executed at scale. Clean Science stands apart: a rare player that has mastered green chemistry at scale, enabling it to export even to China, the world’s one of the largest chemical […]
Neogen Chemicals: From Specialty Player to EV Battery Chemicals
For years, Neogen Chemicals has been known as a niche, high-return specialty chemicals player. But the company is moving from a pure-play specialty chemicals company to a critical supplier for the lithium-ion battery ecosystem. ₹1,500-Crore Bet on India’s EV Future Neogen Chemicals is investing in the future. With a ₹1,500 crore capex plan, the company […]
Afcom Holdings: Play on Air Cargo
Afcom Holdings is betting on building an airport-to-airport cargo business at a time when the market is starved for dedicated capacity. With guaranteed revenues, high load factors, and aggressive fleet expansion, the company sits squarely on strong aviation tailwinds. Industry Tailwinds Structural Growth – Aviation giants like Boeing and Airbus expect air cargo to grow […]